Skip to main content
Springer logoLink to Springer
. 2021 Aug 19;50(1):107–108. doi: 10.1007/s15010-021-01665-y

Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients

Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Jakob J Malin 1,, Christoph D Spinner 2, Uwe Janssens 3, Tobias Welte 4, Steffen Weber-Carstens 5, Gereon Schälte 6, Petra Gastmeier 7, Florian Langer 8, Martin Wepler 9, Michael Westhoff 10, Michael Pfeifer 11,12, Klaus F Rabe 13, Florian Hoffmann 14, Bernd W Böttiger 15, Julia Weinmann-Menke 16, Alexander Kersten 17, Peter Berlit 18, Marcin Krawczyk 19, Wiebke Nehls 20, Falk Fichtner 21, Sven Laudi 21, Miriam Stegemann 22, Nicole Skoetz 23, Monika Nothacker 24, Gernot Marx 25, Christian Karagiannidis 26, Stefan Kluge 27
PMCID: PMC8375461  PMID: 34414563

Correction to: Infection 10.1007/s15010-021-01645-2

The original version of this article, published on July 6, 2021, contained a mistakes.

The affiliation of Dr. Laudi was assigned incorrectly. The correct information is given below.

The title and subtitle of the article were displayed incorrectly. The correct information is given above.

The original article has been corrected.


Articles from Infection are provided here courtesy of Springer

RESOURCES